Search Results

Additional file 1 of MUC20 regulated by extrachromosomal circular DNA attenuates proteasome inhibitor resistance of multiple myeloma by modulating cuproptosis

• Authors : Xiaobin Wang; Yingqing Shi; Hua Shi

Subjects: Biophysics; Biochemistry; Cell Biology

Record details

Delanzomib, a Novel Proteasome Inhibitor, Combined With Adalimumab Drastically Ameliorates Collagen-Induced Arthritis in Rats by Improving and Prolonging the Anti-TNF-α Effect of Adalimumab

• Authors : Lei Wang; Lixiong Liu; Xiaoping Hong

Subjects: musculoskeletal diseases; delanzomib; Arthritis

• Source: Frontiers in Pharmacology, Vol 12 (2021)Frontiers in Pharmacology

Record details

A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies

• Authors : Hongkun Wang; Jimmy J. Hwang; John F. Deeken

Subjects: Adult; Male; 0301 basic medicine

• Source: Cancer Chemother Pharmacol

Record details

Anti-tumor activity of a novel proteasome inhibitor D395 against multiple myeloma and its lower cardiotoxicity compared with carfilzomib

• Authors : Lina Zhang; Chao Wu; Haoyang Zhang

Subjects: Male; Cancer Research; Immunology

• Source: Cell Death & DiseaseCell Death and Disease, Vol 12, Iss 5, Pp 1-13 (2021)

Record details

Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomib against Bortezomib-Resistant Leukemia Cells and Primary Acute Leukemia Cells

• Authors : Gertjan J.L. Kaspers; Sonja Zweegman; Johan van Meerloo ...

Subjects: 0301 basic medicine; Boron Compounds; ixazomib

• Source: Roeten, M S F, van Meerloo, J, Kwidama, Z J, ter Huizen, G, Segerink, W H, Zweegman, S, Kaspers, G J L, Jansen, G & Cloos, J 2021, ' Pre-Clinical Evaluation of the

Record details

Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing on Fulvestrant

• Authors : Bianca Romo; Alexei F. Kisselev; Jonathan D. Marotti

Subjects: 0301 basic medicine; Boron Compounds; Cancer Research

• Source: Oncologist

Record details

Lactacystin: first-in-class proteasome inhibitor still excelling and an exemplar for future antibiotic research

• Authors : Andy Crump; Satoshi Ōmura

Subjects: 0301 basic medicine; Computer science; 030106 microbiology

• Source: The Journal of Antibiotics

Record details

Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor–refractory multiple myeloma

• Authors : Christoph Driessen; Andrej Besse; Panagiotis Samaras

Subjects: 0301 basic medicine; Immunology; Proteasome inhibitors

• Source: Blood, Vol. 132, No 19 (2018) pp. 2097-2100

Record details

Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor

• Authors : Michael J. Hanley; Cindy Q. Xia; Neeraj Gupta

Subjects: Boron Compounds; 0301 basic medicine; Population

• Source: Clinical Pharmacokinetics

Record details

Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized Mice

• Authors : Roland A. Cooper; Thijs Beuming; Philip J. Rosenthal

Subjects: Models, Molecular; Proteasome Endopeptidase Complex; Plasmodium falciparum

• Source: Angew Chem Int Ed Engl

Record details